Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 721–744 of 2,615 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Sleep-Wake Disorders Clear all

Conditions: Sleep Apnea, Obstructive
Interventions: Modafinil; Drug
Lead sponsor: Cephalon; Industry
Eligibility: 6 Years to 16 Years
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2005
U.S. locations: 60
States / cities: Birmingham, Alabama • Tucson, Arizona • Fort Smith, Arkansas + 51 more

Conditions: Sickle Cell Disease, Sleep Disturbance, Pain
Interventions: Behavioral symptom management, Sickle cell disease management; Behavioral · Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Shift Work Type Circadian Rhythm Sleep Disorder, Diabetes Mellitus, Type 2, Circadian Rhythm Sleep Disorder, Shift Work Type, Insulin Resistance
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 60 Years
Enrollment: 365 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension, Obstructive Sleep Apnea
Interventions: Not listed
Lead sponsor: NYU Langone Health; Other
Eligibility: 10 Years to 17 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Mineola, New York

Conditions: Sleep Deprivation
Interventions: Sleep deprivation; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 40 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Ischemic Stroke
Interventions: Non-invasive ventilatory treatment with auto-BPAP; Device
Lead sponsor: Technische Universität Dresden; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2013
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Sleep Apnea, Obstructive, Type 1 Diabetes (T1D)
Interventions: Continuous positive airway pressure (CPAP); Device
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 50 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Obstructive Sleep Apnea
Interventions: Group A : provided with 1 Whitsundays Nasal mask without a spare mask cushion, Group B : provided with 1 Whitsundays Nasal mask with 2 spare mask cushions; Device
Lead sponsor: ResMed; Industry
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 2
States / cities: San Diego, California • St Louis, Missouri

Conditions: Developmental Disabilities, Sleep Disorders, Polysomnography, Preparation for Medical Procedure, Child
Interventions: Educational Story; Other
Lead sponsor: Jennifer Accardo; Other
Eligibility: 4 Years to 17 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Brain Tumors, Epilepsy, Migraine, Mild Cognitive Impairment, Concussion, Multiple Sclerosis, Neuropathy, Parkinson's, Restless Legs Syndrome, Stroke
Interventions: Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description); Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 100 Years
Enrollment: 3,300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Sleep Disorders
Interventions: Circadin 2/5/10 mg, Placebo; Drug
Lead sponsor: Neurim Pharmaceuticals Ltd.; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 18
States / cities: Phoenix, Arizona • Miami Lakes, Florida • Orange City, Florida + 14 more

Conditions: Excessive Daytime Sleepiness, Parkinson Disease
Interventions: BEN-2001, Placebo; Drug
Lead sponsor: BenevolentAI Bio; Industry
Eligibility: 50 Years to 80 Years
Enrollment: 244 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Insomnia
Interventions: Internet, DVD; Behavioral
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 6 Months to 36 Months
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Back Pain, Insomnia
Interventions: Active Mattress Cover, Placebo Mattress Cover; Device
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Orange, California

Conditions: Obstructive Sleep Apnea Syndrome, Polycystic Ovary Syndrome, Sleep Apnea
Interventions: Nasal Continuous positive airway pressure (CPAP); Device
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 13 Years to 21 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Sleep Disorder, Pre Diabetes, Obstructive Sleep Apnea
Interventions: Lifestyle Intervention; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Sleep Apnea
Interventions: Atomoxetine, Oxybutynin, Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years to 70 Years
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Parkinson Disease, Sleep Disturbance
Interventions: Tailored Lighting Intervention (TLI), Actigraph; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Heart Failure, Central Sleep Apnea
Interventions: Oxygen, Room Air; Drug · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 26
States / cities: Tucson, Arizona • Stanford, California • New Haven, Connecticut + 20 more

Conditions: Sleep Disordered Breathing
Interventions: AD036, Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 25 Years to 70 Years
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Narcolepsy
Interventions: sodium oxybate; Drug
Lead sponsor: Orphan Medical; Industry
Eligibility: 16 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2004
U.S. locations: 37
States / cities: Birmingham, Alabama • La Jolla, California • Stanford, California + 31 more

Conditions: Sleep Apnea, Obstructive
Interventions: Placebo, Dalfampridine; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Insomnia, Cardiovascular Risk Factor
Interventions: Cognitive-Behavior Therapy for Insomnia (CBT-I); Behavioral
Lead sponsor: Walter Reed National Military Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: CALR Gene Mutation, Essential Thrombocythemia, JAK2 Gene Mutation, MPL Gene Mutation, Obstructive Sleep Apnea Syndrome, Polycythemia Vera
Interventions: Continuous Positive Airway Pressure, Patient Observation, Questionnaire Administration; Procedure · Other
Lead sponsor: University of Utah; Other
Eligibility: 30 Years to 85 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: Salt Lake City, Utah

Search by objective public record fields.

Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome

Sleep and Pain in Sickle Cell Disease

Shift Work, Heredity, Insulin, and Food Timing Study

Hypertension and Sleep Disordered Breathing in Pediatrics

Quantifying and Developing Countermeasures for the Effect of Fatigue-Related Stressors on Automation Use and Trust During Robotic Supervisory Control

Reversal of the Neurological Deficit in Acute Stroke With the Signal of Efficacy Trial of Auto BPAP to Limit Damage From Suspected Sleep Apnea

Type 1 Diabetes and Obstructive Sleep Apnea

Whitsundays (Nasal) Mask Take Home Study (90 Days)

Use of an Educational Story to Prepare Children With Developmental Disabilities for Sleep Study

Quality Improvement and Practice Based Research in Neurology Using the EMR

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

BEN-2001 in Parkinson Disease Patients With Excessive Daytime Sleepiness

Helping Young Children Sleep

Trial on the Effect of Optically Modified Fiber Mattress Covers on Sleep Disturbances in Patients With Chronic Back Pain

Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents

Recruitment Strategies Comparing Different Strategies in Sleep Apnea and Prediabetes

A Novel Pharmacological Therapy for Obstructive Sleep Apnea

The Effect of a Lighting Intervention on Sleep in Parkinson Disease

The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep Apnea

Pharmacological Intervention for Symptomatic Mild Sleep Disordered Breathing

Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients

Effect of Dalfampridine (4-AP) on Genioglossus Muscle Activity in Healthy Adults

Integrative Cardiac Health Project Cognitive-Behavior Therapy for Insomnia

CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia